The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLAM.L Regulatory News (LAM)

  • There is currently no data for LAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of 2018 AGM

23 May 2018 08:15

RNS Number : 9917O
Lamprell plc
23 May 2018
 

 

 

23 May 2018

 

LAMPRELL PLC("Lamprell" or the "Company", and with its subsidiaries the "Group")

 

RESULTS OF 2018 AGM

 

 

At the Annual General Meeting of the Company held at 10.00AM (local time) yesterday at 7th Floor, Jumeirah Emirates Tower, Sheikh Zayed Road, Dubai, United Arab Emirates, all the resolutions set out in the Notice of Annual General Meeting ("AGM Notice") published by the Company on 23 April 2018 were duly passed.

 

Voting on all resolutions was by way of a show of hands. Voting on resolutions 8, 10 and 12 was by Independent Shareholders (as defined in the AGM Notice) only.

 

FINAL PROXY VOTING TOTALS

 

Details of the final proxy votes received in respect of the resolutions proposed at the Annual General Meeting are as follows:

 

Resolution no

Business

TOTAL SHARES VOTED

FOR/ DISCRETION

AGAINST

WITHHELD

Ordinary Business

1

To receive and adopt the Company's financial statements together with the reports of the directors and auditors for the period ending 31 December 2017

277,563,208

277,563,208

0

1,846,528

2

To approve the Directors' annual report on remuneration for the year ended 31 December 2017 included in the 2017 Annual Report and Accounts

279,408,478

204,758,392

74,650,086

1,259

3

To elect John Malcolm as a director of the Company

279,409,073

273,475,322

5,933,751

663

4

To elect Christopher McDonald as a director of the Company

279,409,336

276,366,654

3,042,682

401

5

To elect Antony Wright as a director of the Company

279,409,074

275,208,489

4,200,585

663

6

To elect Nicholas Garrett as a director of the Company

279,409,336

274,539,666

4,869,670

401

7

To elect James Dewar as a director of the Company

279,409,336

279,405,850

3,486

401

8

To elect James Dewar as a director of the Company (Independent Shareholder vote)

166,219,945

166,216,721

3,224

401

9

To elect Debra Valentine as a director of the Company

279,409,073

269,239,204

10,169,869

663

10

To elect Debra Valentine as a director of the Company (Independent Shareholder vote)

166,227,045

164,127,692

2,099,353

401

11

To elect Mel Fitzgerald as a director of the Company

279,409,335

272,307,560

7,101,775

401

12

To elect Mel Fitzgerald as a director of the Company (Independent Shareholder vote)

166,227,044

162,246,148

3,980,896

401

13

To appoint Deloitte LLP, Isle of Man, as auditors of the Company

279,408,227

279,406,659

1,568

1,510

14

To authorise the directors to fix the auditors' remuneration

279,407,473

279,405,905

1,568

2,264

Special Business

 

15

To authorise the directors to allot shares pursuant to Article 5.1 of the Company's Articles of Association

279,408,582

279,404,784

3,798

1,155

16

To disapply the pre-emption rights pursuant to article 5.2 of the Company's Articles of Association

279,408,582

279,396,784

11,798

1,155

17

To authorise the Company to make market purchases of its ordinary shares

279,408,982

276,729,442

2,679,540

754

 

 

Our 2017 Directors' annual report on remuneration has been approved by shareholders with 73.3% of votes cast in favour of the resolution. While the Board is disappointed not to have received a higher level of support for the resolution given the report's conformity with our existing remuneration policy, we understand the specific concern raised by our shareholders and we will continue to actively engage with them on executive remuneration and other issues.

 

 

 

Notes to proxy voting totals table:

 

1. Any proxy appointments which gave discretion to the Chairman have been included in the 'FOR' total.

 

2. A 'VOTE WITHHELD' is not a vote in law and is not counted in the calculation of the proportion of votes for or against a resolution and is not included in the total proxy votes received for each resolution.

 

3. Number of ordinary shares of 5 pence each in issue at meeting date: 341,726,570.

 

4. The Controlling Shareholder (as defined in the AGM Notice) was not eligible to vote on resolutions 8, 10 and 12. The Controlling Shareholder holds a total of 113,182,291 Ordinary Shares, equating to 33.12% of the issued ordinary share capital with voting rights.

 

** These votes reflect the results of the poll taken during the meeting, rather than the proxy votes received.

 

Copies of the resolutions passed as Special Business will be submitted to the National Storage Mechanism and will be available for inspection at http://www.morningstar.co.uk/uk/nsm.

 

 

- Ends -

 

 

Enquiries:

 

Lamprell plc

Alex Ridout, Company Secretary

+971 (0) 4 803 9308

Maria Babkina

+44 (0) 7852 618 046

Tulchan Communications, London

Martin Robinson

+44 (0) 207 353 4200

Martin Pengelley

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGUOABRWUAVURR
Date   Source Headline
6th Jul 20217:00 amRNSHolding(s) in Company
29th Jun 20216:08 pmRNS2020 Annual Report and Accounts
29th Jun 20217:00 amRNS2020 Financial Results
15th Jun 20217:00 amRNSUpdate to release date of 2020 financial results
13th May 20217:00 amRNSUpdate to release date of 2020 Financial Results
28th Apr 20211:28 pmRNSNew Contract Award
23rd Apr 20217:00 amRNSUpdate to release date of 2020 Financial Results
30th Mar 20217:00 amRNSInjazat and Lamprell announce joint venture
8th Mar 20217:00 amRNSRevised date for full year results
24th Feb 20218:00 amRNSNew Contract Award
1st Feb 20217:00 amRNSPDMR Shareholdings
21st Jan 20218:12 amRNSHolding(s) in Company
18th Jan 20217:00 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSStrategic Re-organisation and Trading Update
20th Nov 20207:00 amRNSHolding(s) in Company
12th Nov 20209:09 amRNSUpdate on IMI joint venture
5th Nov 20207:00 amRNSHolding(s) in Company
2nd Nov 20207:00 amRNSNew Contract Award
5th Oct 20207:00 amRNSDirector/PDMR Shareholding
1st Oct 20207:00 amRNS2020 Interim Results
3rd Sep 202010:37 amRNSHolding(s) in Company
22nd Jul 20207:00 amRNSTrading Update
25th Jun 20204:05 pmRNSResult of AGM 2020
24th Jun 202012:02 pmRNSHolding(s) in Company
23rd Jun 20202:27 pmRNSUpdate on Seagreen contract award
15th Jun 20204:36 pmRNSPrice Monitoring Extension
5th Jun 20204:02 pmRNSNew Contract Award
27th May 20207:00 amRNSNotice of AGM/Annual Report and Accounts
20th May 20204:41 pmRNSSecond Price Monitoring Extn
20th May 20204:35 pmRNSPrice Monitoring Extension
20th May 20207:00 amRNSNew Contract Award
13th May 20207:00 amRNS2019 Full Year Results
5th May 20202:49 pmRNSUpdated release date of the 2019 Financial Results
4th May 20207:00 amRNSHolding(s) in Company
23rd Apr 20201:42 pmRNSEast Anglia One - final contract settlement
14th Apr 20207:00 amRNSUpdate on restructuring/Covid19 self-help measures
8th Apr 20204:35 pmRNSPrice Monitoring Extension
24th Mar 20204:38 pmRNSPrice Monitoring Extension
23rd Mar 20207:36 amRNSUpdated release date of the 2019 financial results
20th Mar 20204:45 pmRNSSecond Price Monitoring Extn
20th Mar 20204:38 pmRNSPrice Monitoring Extension
17th Mar 20204:43 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
12th Mar 20204:41 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
9th Mar 20207:00 amRNSDirector/PDMR Shareholding
12th Feb 20207:00 amRNSDigital collaboration with Akselos
10th Feb 20207:00 amRNSDirectorate Change
20th Jan 20207:00 amRNSNew Contract Award
16th Jan 20207:00 amRNSPre-close Trading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.